Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
gout
Biotech
Selecta narrows focus to gout drug, freezing rest of pipeline
Three months after laying off a quarter of its workforce, Selecta is halting investment in all but one of its non-partnered programs.
James Waldron
Aug 17, 2023 8:18am
Selecta, Sobi rout gout in phase 3 trials to take on Horizon
Mar 21, 2023 7:40am
Alnylam culls 3 programs, including once-touted nephropathy med
Dec 16, 2022 1:52pm
Innovent pays nearly $100M for China rights to LG Chem gout med
Dec 15, 2022 10:10am
Arrowhead pointed toward Horizon with $40M upfront for gout drug
Jun 21, 2021 10:20am
Selecta lays off staff as R&D cash crunch looms
Jan 4, 2019 8:45am